✦ LIBER ✦

Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia Burden

✍ Scribed by Zhang, Wei-Ping; Yang, Dan; Song, Xian-Min; Ni, Xiong; Chen, Jie; Chen, Li; Yang, Jian-min; Zhou, Hong; Cheng, Hui; Liu, Bao-hai; Li, Hong-Mei; Wang, Jian-Min

Book ID: 123155249
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 498 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.01.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low Risk of Chronic Graft-versus-Host Di

Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303

✍ Steven M. Devine; Shelly Carter; Robert J. Soiffer; Marcelo C. Pasquini; Parames 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 327 KB

The risk of residual molecular and cytog

The risk of residual molecular and cytogenetic disease in patients with philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow: A. Elmaagacli, D. Beelen, B. Opalka, et al. Blood 94:384–389, 1999

✍ Christopher D. Hillyer 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB